- NZ$10.18m
- NZ$42.74m
- NZ$26.19m
- 60
- 99
- 65
- 84
Annual income statement for Vital, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.9 | 34.6 | 30.7 | 27.5 | 26.2 |
Cost of Revenue | |||||
Gross Profit | 16 | 13.7 | 11.1 | 12 | 12.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.4 | 31.6 | 48.4 | 24.8 | 23.2 |
Operating Profit | 3.52 | 2.99 | -17.7 | 2.69 | 2.96 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1.02 | 1.16 | -19.9 | -0.275 | -0.068 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.734 | 0.841 | -19.1 | -0.183 | 0.027 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.734 | 0.841 | -19.1 | -0.183 | 0.027 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.734 | 0.841 | -19.1 | -0.183 | 0.027 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.018 | 0.02 | -0.193 | -0.004 | 0.001 |
Dividends per Share | |||||
Special Dividends per Share |